AxoGen (AXGN) Tops Q3 EPS by 5c

AxoGen (NASDAQ: AXGN) reported Q3 EPS of $0.12, $0.05 better than the analyst estimate of $0.07. Revenue for the quarter came in at $60.1 million versus the consensus estimate of $56.94 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• In memo, Meta says it plans to crack down on employee token use as AI costs soar - The Information
• Roku Said To Be In Sale Talks, Including Possible Media Tie-up - Bloomberg